FDA Approves Another Pair of Denosumab Biosimilars, Conexxence and Bomyntra

Patients with postmenopausal osteoporosis experienced adverse events (AEs) including back pain, hypercholesterolemia, musculoskeletal pain, and …
Source: back pain